Le Lézard
Classified in: Health, Science and technology, Covid-19 virus
Subject: SVY

Technical Ceramics to Drive Innovative Ecosystem in Electronics and Energy, Says Frost & Sullivan


SANTA CLARA, Calif., July 13, 2020 /CNW/ -- Frost & Sullivan's recent analysis, Growth Opportunities for Technical Ceramics, projects the growing demand for a wide variety of goods made of technical ceramics due to rising environmental concerns and stringent regulations by governments, especially in the European region, which further propel innovation and research and development (R&D) efforts in the market.

For further information on this analysis, please visit: http://frost.ly/46v

"Technical ceramics, especially oxides and silicates, have gained immense popularity in the last few years due to their durability and high tensile strength. The superior properties of technical ceramics significantly reduce time-to-market and the cycle time of components made from them, allowing manufacturers to launch multifunctional technical ceramic products," said Sanchari Chatterjee, Industry Analyst, TechVision at Frost & Sullivan. "Globally, technical ceramics will be able to create a new demand for a wide variety of goods made using the material, including household basics to high-end decorative glass and tiles, to medical and dental devices. The North American and European markets are extremely attractive for technical ceramics and will witness growth."

Chatterjee added: "The manufacture of technical ceramics may be slightly impacted by the COVID-19 pandemic due to delayed operations in manufacturers. However, adoption from end industries is expected to remain unchanged due to the exceptional potential of technical ceramics with regards to their multiple functions, compared to traditional polymers, ceramics or metals."

To capitalize on the expected growth in demand, market participants should:

Growth Opportunities for Technical Ceramics is part of Frost & Sullivan's global TechVision Growth Partnership Service program.

About Frost & Sullivan

For over five decades, Frost & Sullivan has become world-renowned for its role in helping investors, corporate leaders and governments navigate economic changes and identify disruptive technologies, Mega Trends, new business models and companies to action, resulting in a continuous flow of growth opportunities to drive future success. Contact us: Start the discussion.

Growth Opportunities for Technical Ceramics
D98C-TV

Contact:

Zuzana Zukarnain
Corporate Communications
T: +60192657808
E: zuzana.zukarnain@frost.com

http://ww2.frost.com

 

SOURCE Frost & Sullivan


These press releases may also interest you

at 02:16
Immunovia invites to a teleconference (in English) for investors, analysts and media on Thursday, August 20th, 2020 at 16:30 CET. Immunovia will publish the company's interim report on August 20th, 2020 at 16:00 CET. Mats Grahn, CEO will present...

at 02:05
Gyroscope Therapeutics Limited, a clinical-stage retinal gene therapy company, today announced the initiation of its Phase II programme evaluating its investigational gene therapy, GT005, for the treatment of geographic atrophy (GA) secondary to dry...

at 02:00
Utilizing Bluetooth Low Energy ("BLE") technology, Mobile Programming LLC has developed a COVID-19 Contact Tracing Application to help organizations get back to work safely, while addressing COVID-19 health and safety concerns. Because COVID-19 is...

at 01:36
"In June we successfully closed a $90m U.S. IPO on NASDAQ, which including the greenshoe that was exercised in July, resulted in gross proceeds of $97m in total. This successful and pioneering transaction, which was the first time a Swedish life...

at 01:21
Transaction adds late-stage orphan pipeline asset and platform in inflammation and fibrosis. Calliditas to acquire 62.7% of Genkyotex for ?20.3M in cash at ?2.80 per share in an off-market transaction. Following the closing of the control transaction...

at 01:10
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) accepted the company's supplemental Biologics License Application (sBLA) for a new self-administration option for...



News published on 13 july 2020 at 07:13 and distributed by: